MRI of blood volume with MS 325 in experimental choroidal melanoma

Magnetic Resonance Imaging

Volumn 21, Issue 7, 2003, Pages 725-732

  Krause, Matthias H J ^a   Kwong, Kenneth K ^a   Xiong, Jing ^a   Gragoudas, Evangelos S ^a   Young, Lucy H Y ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Blood volume; Choroid; Melanoma; Neoplasms; Nuclear magnetic resonance; Pathology; Physiopathology

Indexed keywords

CYCLOSPORIN A; GADOFOSVESET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CHOROID MELANOMA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; EYE BLOOD FLOW; FEMALE; HISTOPATHOLOGY; LOW LEVEL LASER THERAPY; NEODYMIUM LASER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0141992811     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(03)00100-0     Document Type: Article

References (49)

1. Mafee MF. Uveal melanoma, choroidal hemangioma, and simulating lesions. Radiologic Clinics of North America 1998;36:1083-99.
2. Mafee MF, Peyman GA, Grisolano JE, Fletcher ME, Spigos DG, Wehrli FW, Rasouli F, Capek V. Malignant uveal melanoma and simulating lesions: MR imaging evaluation. Radiology 1986;160(3):773-80.
3. De Potter P, Flanders AK, Shields JA, Shields CL, Gonzales CF, Rao VM. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions [see comments]. Arch Ophthalmol 1994;112(3):340-8.
4. Peyster RG, Augsburger JJ, Shields JA, Hershey BL, Eagle R, Haskin ME. Intraocular tumors: evaluation with MR imaging. Radiology 1988;168(3):773-9.
5. Chambers RB, Davidorf FH, McAdoo JF, Chakeres DW. Magnetic resonance imaging of uveal melanomas. Arch Ophthalmol 1987; 105(7):917-21.
6. Bond JB, Haik BG, Mihara F, Gupta KL. Magnetic resonance imaging of choroidal melanoma with and without gadolinium contrast enhancement. Ophthalmology 1991;98(4):459-66.
7. Flindall RJ, Gass JD. A histopathologic fluorescein angiographic correlative study of malignant melanomas of the choroid. Can J Ophthalmol 1971;6(4):258-67.
8. Leff SR, Augsburger JJ, Shields JA. Focal fluorescence of choroidal melanoma. Br J Ophthalmol 1986;70(2):104-6.
9. Cantrill HL, Cameron JD, Ramsay RC, Knobloch WH. Retinal vascular changes in malignant melanoma of the choroid. Am J Ophthalmol 1984;97(4):411-8.
10. Kim RY, Hu LK, Foster BS, Gragoudas ES, Young LH. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. Ophthalmology 1996;103(12):2029-36.
11. Moonen CT, van Zijl PC, Frank JA, Le Bihan D, Becker ED. Functional magnetic resonance imaging in medicine and physiology. Science 1990;250(4977):53-61.
12. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989;5:263-81.
13. Belliveau JW, Kennedy DN, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, Vevea JM, Brady TJ, Rosen BR. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991;254(5032):716-9.
14. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992;23(1):37-45.
15. Kwong KK, Chester DA, Weisskoff RM, Donahue KM, Davis TL, Ostergaard L, Campbell TA, Rosen BR. MR perfusion studies with T1-weighted echo planar imaging. Magn Reson Med 1995;34(6):878-87.
16. Kwong KK, Chesier DA, Weisskoff RM, Rosen BR. Perfusion imaging. In: Proc. SMK 2nd Annu Meeting, San Francisco, 1994.
17. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water [published erratum appears in Proc Natl Acad Sci U S A 1992 May 1;89(9): 4220]. Proc Natl Acad Sci U S A 1992;89(1):212-6.
18. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water [published erratum appears in Proc Natl Acad Sci U S A 1992 May 1;89(9): 4220]. Proc Natl Acad Sci U S A 1992;89(1):212-6.
19. Wong EC, Buxton RB, Frank LR. Implementation of quantitative perfusion imaging techniques for functonal brain mapping using pulsed arterial spin labeling [see comments]. NMR Biomed 1997; 10(4-5):23749.
20. Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997;32(12):741-7.
21. Mandeville JB, Marota J, Keltner JR, Kosofsky B, Burke J, Hyman S, LaPointe L, Reese T, Kwong K, Rosen B, Weissleder R, Weisskoff R. CBV functional imaging in rat brain using iron oxide agent at steady state concentration. In: ISMRM, 4th Annual Meeting; 1996; New York; 1996. p. 292.
22. Mandeville JB, Marota JJ, Kosofsky BE, Keltner JR, Weissleder R, Rosen BR, Weisskoff RM. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 1998;39(4):615-24.
23. Gonzalez VH, Hu LK, Theodossiadis PG, Flotte TJ, Gragoudas ES, Young LH. Photodynamic therapy of pigmented choroidal melanomas. Invest Ophthalmol Vis Sci 1995;36(5):871-8.
24. Krause M, Xiong J, Gragoudas ES, Young LHY. Treatment of experimental choroidal melanomas with a Nd: YLF laser at 1047 nm. IOVS 2001;42:S220.
25. Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995;113(3):315-21.
26. Roberts DJH, Cairnduff F, Driver I, Dixon B, Brown SB. Tumor vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid. Int J Oncol 1994;5:763-768.
27. Henderson BW, Vaughan L, Bellnier DA, van Leengoed H, Johnson PG, Oseroff AR. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem Photobiol 1995;62(4):780-9.
28. Henderson BW, Fingar VH. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem Photobiol 1989;49(3):299-304.
29. Star WM, Marijnissen HP, van den Berg-Blok AK, Versteeg JA, Franken KA, Reinhold HS. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 1986;46(5):2532-40.
30. Nelson JS, Liaw LH, Orenstein A, Roberts WG, Berns MW. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J Natl Cancer Inst 1988; 80(20):1599-605.
31. Hu LK, Huh K, Gragoudas ES, Young LH. Establishment of pigmented choroidal melanomas in a rabbit model. Retina 1994;14(3):264-9.
32. Pineda R, Theodossiadis PG, Gonzalez VH, Hu LK, Hart LJ, Gragoudas ES, Young LH. Establishment of a rabbit model of extrascleral extension of ocular melanoma. Retina 1998;18(4):368-72.
33. Dewey D. Corneal and retinal energy density with various laser beam delivery systems and contact lenses. In: Puliafito CA, editor. Ophthalmic Technologies: Proceedings of the Society of Photo-Optical Instrumentation Engineers; 1991 January 20-25, 1991; Los Angeles: The International Society for Optical Engineering; 1991. p. 105-116.
34. Lauffer RB, Parmelee DJ, Dunham SU, Ouellet HS, Dolan RP, Witte S, McMurry TJ, Walovitch RC. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207(2):529-38.
35. Grist TM, Korosec FR, Peters DC, Witte S, Walovitch RC, Dolan RP, Bridson WE, Yucel EK, Mistretta CA. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998;207(2):539-44.
36. Lauffer RB, Parmelee DJ, Ouellet HS, Dolan RP, Sajiki H, Scott DM, Bernard PJ, Buchanan EM, Ong KY, Tyeklar Z, Midelfort KS, McMurry TJ, Walovitch RC. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol 1996; 3(Suppl 2):S356-8.
37. Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 1993;28(Suppl 1):S28-43.
38. He XM, Carter DC. Atomic structure and chemistry of human serum albumin [published erratum appears in Nature 1993 Jul 22;364(6435): 362]. Nature 1992;358(6383):209-15.
39. He XM, Carter DC. Atomic structure and chemistry of human serum albumin [published erratum appears in Nature 1993 Jul 22;364(6435): 362]. Nature 1992;358(6383):209-15.
40. Weissleder R, Cheng HC, Marecos E, Kwong K, Bogdanov A. Non-invasive in vivo mapping of tumour vascular and interstitial volume fractions. Eur J Cancer 1998;34(9):1448-54.
41. Donahue KM, Weisskoff RM, Chesler DA, Kwong KK, Bogdanov M, Mandeville JB, Rosen BR. Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. Magn Reson Med 1996;36(6):858-67.
42. Schwickert HC, Roberts TP, Shames DM, van Dijke CF, Disston A, Muhler A, Mann JS, Brasch RC. Quantification of liver blood volume: comparison of ultra short T1 inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995;34(6):845-52.
43. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol 1994;62(1):209-13.
44. Hamberg LM, Boccalini P, Stranjalis G, Hunter GJ, Huang Z, Halpern E, Weisskoff RM, Moskowitz MA, Rosen BR. Continuous assessment of relative cerebral blood volume in transient ischemia using steady state susceptibility-contrast MRI. Magn Reson Med 1996;35(2):168-73.
45. Meyer KL, Joseph PM, Mukherji B, Livolsi VA, Lin R. Measurement of vascular votume in experimental rat tumors by 19F magnetic resonance imaging. Invest Radiol 1993;28(8):710-9.
46. Su MY, Jao JC, Nalcioglu O. Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med 1994;32(6):714-24.
47. Brasch R, Pham C, Shames D, Roberts T, van Dijke K, van Bruggen N, Mann J, Ostrowitzki S, Melnyk O. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7(1):68-74.
48. Enochs WS, Hyslop WB, Bennett HF, Brown RDd, Koenig SH, Swartz HM. Sources of the increased longitudinal relaxation rates observed in melanotic melanoma. An in vitro study of synthetic melanins. Invest Radiol 1989;24(10):794-804.
49. Bradley W. Flow phenomena; in: Stark D, Bradley W. (eds): Magnetic resonance imaging. 2nd (ed): St. Louis, Baltimore, Boston, Chicago, London, Philadelphia, Sydney, Toronto, Mosby, 1992:253-298.